1. Home
  2. AUTL vs WLDN Comparison

AUTL vs WLDN Comparison

Compare AUTL & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUTL
  • WLDN
  • Stock Information
  • Founded
  • AUTL 2014
  • WLDN 1964
  • Country
  • AUTL United Kingdom
  • WLDN United States
  • Employees
  • AUTL N/A
  • WLDN N/A
  • Industry
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • WLDN Military/Government/Technical
  • Sector
  • AUTL Health Care
  • WLDN Consumer Discretionary
  • Exchange
  • AUTL Nasdaq
  • WLDN Nasdaq
  • Market Cap
  • AUTL 590.8M
  • WLDN 581.0M
  • IPO Year
  • AUTL 2018
  • WLDN 2006
  • Fundamental
  • Price
  • AUTL $2.17
  • WLDN $35.06
  • Analyst Decision
  • AUTL Strong Buy
  • WLDN Strong Buy
  • Analyst Count
  • AUTL 3
  • WLDN 3
  • Target Price
  • AUTL $10.20
  • WLDN $44.33
  • AVG Volume (30 Days)
  • AUTL 1.1M
  • WLDN 96.5K
  • Earning Date
  • AUTL 03-13-2025
  • WLDN 03-06-2025
  • Dividend Yield
  • AUTL N/A
  • WLDN N/A
  • EPS Growth
  • AUTL N/A
  • WLDN 802.09
  • EPS
  • AUTL N/A
  • WLDN 1.63
  • Revenue
  • AUTL $10,091,000.00
  • WLDN $577,414,000.00
  • Revenue This Year
  • AUTL $851.83
  • WLDN N/A
  • Revenue Next Year
  • AUTL $224.65
  • WLDN $7.28
  • P/E Ratio
  • AUTL N/A
  • WLDN $21.53
  • Revenue Growth
  • AUTL 82.71
  • WLDN 23.47
  • 52 Week Low
  • AUTL $2.07
  • WLDN $18.78
  • 52 Week High
  • AUTL $7.37
  • WLDN $50.00
  • Technical
  • Relative Strength Index (RSI)
  • AUTL 41.81
  • WLDN 31.17
  • Support Level
  • AUTL $2.11
  • WLDN $34.75
  • Resistance Level
  • AUTL $2.26
  • WLDN $37.82
  • Average True Range (ATR)
  • AUTL 0.12
  • WLDN 0.92
  • MACD
  • AUTL 0.01
  • WLDN -0.13
  • Stochastic Oscillator
  • AUTL 27.78
  • WLDN 7.31

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

Share on Social Networks: